Patent details

EP1545516 Title: TOPICAL FORMULATION COMPRISING AT LEAST 10% OF METRONIDAZOLE IN WHITE PETROLATUM AND ITS USE IN THE ANAL AND RECTAL REGION

Basic Information

Publication number:
EP1545516
PCT Application Number:
PCT/GB/2003/003692
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP037925211
PCT Publication Number:
WO/2004/017962
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TOPICAL FORMULATION COMPRISING AT LEAST 10% OF METRONIDAZOLE IN WHITE PETROLATUM AND ITS USE IN THE ANAL AND RECTAL REGION
French Title of Invention:
FORMULATION TOPIQUE A BASE DE VASELINE COMPRENANT AU MOINS 10% DE METRONIDAZOLE POUR APPLICATION RECTALE ET ANALE
German Title of Invention:
TOPISCHE FORMULIERUNG MIT MINDESTENS 10% METRONIDAZOL IN ENTFÄRBTEM PETROLATUM UND IHRE VERWENDUNG IM ANAL- UND REKTALBEREICH
SPC Number:

Dates

Filing date:
22/08/2003
Grant date:
03/09/2008
EP Publication Date:
03/09/2008
PCT Publication Date:
04/03/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/06/2005
EP B1 Publication Date:
03/09/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/08/2015
Expiration date:
22/08/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/08/2003
 
 

Name:
S.L.A. Pharma AG
Address:
Rebgasse 2, 4410 Liestal, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
29/10/2008
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
ARMSTRONG David, Nigel
Address:
United States (US)

Priority

Priority Number:
406351 P
Priority Date:
26/08/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/4164;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages